Dive into the evolving landscape of endometrial cancer, including rising incidence, classification, racial disparities, and emerging modalities, as discussed by experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD.
FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer
Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers
ChatGPT Displays Potential for Genetic Counseling in Gynecologic Oncology
Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
Sinno Spotlights Key Clinical Trials Driving Targeted Approaches in Gynecologic Oncology
Dr Shore on the Importance of a Multidisciplinary Team in Urologic Oncology
Apalutamide/ADT Demonstrates 100% Biochemical RFS Rate in High-Risk Prostate Cancer
Prior Abiraterone Strengthens Outcomes With Lutetium Lu 177 Vipivotide Tetraxetan in mCRPC
18F-PSMA-1007 PET/CT Provides Staging Benefit Over MRI in Prostate Cancer